These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 21434303

  • 1. [Endocervical adenocarcinoma--a current diagnostic problem].
    Marinova P, Rampalova G, Kolnikova S, Orthova S, Ondriasch F.
    Akush Ginekol (Sofiia); 2010; 49(7):35-41. PubMed ID: 21434303
    [Abstract] [Full Text] [Related]

  • 2. Glandular lesions of the uterine cervix.
    Zaino RJ.
    Mod Pathol; 2000 Mar; 13(3):261-74. PubMed ID: 10757337
    [Abstract] [Full Text] [Related]

  • 3. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D, Baalbergen A, Helmerhorst TJ.
    Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):977-80. PubMed ID: 18549169
    [Abstract] [Full Text] [Related]

  • 4. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ, Kenny MB, Naib ZM.
    Acta Cytol; 1991 Apr 26; 35(1):127-34. PubMed ID: 1994621
    [Abstract] [Full Text] [Related]

  • 5. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY, Stanbridge EJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 26; 5(7):549-57. PubMed ID: 8827360
    [Abstract] [Full Text] [Related]

  • 6. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, Vazquez M.
    Diagn Cytopathol; 2006 Mar 26; 34(3):235-9. PubMed ID: 16470857
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, Shim JU.
    Gynecol Oncol; 1999 May 26; 73(2):292-8. PubMed ID: 10329049
    [Abstract] [Full Text] [Related]

  • 8. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ.
    Am J Surg Pathol; 2010 Feb 26; 34(2):137-46. PubMed ID: 20061933
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK.
    APMIS Suppl; 1998 Feb 26; 80():1-41. PubMed ID: 9693662
    [Abstract] [Full Text] [Related]

  • 10. Use of p63 for distinction of glandular versus squamous lesions in cervicovaginal specimens.
    Garcia MT, Acar BC, Jorda M, Gomez-Fernandez C, Ganjei-Azar P.
    Cancer; 2007 Feb 25; 111(1):54-7. PubMed ID: 17173320
    [Abstract] [Full Text] [Related]

  • 11. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H, Hocking J, Saville M.
    Cancer; 2003 Dec 25; 99(6):336-41. PubMed ID: 14681940
    [Abstract] [Full Text] [Related]

  • 12. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM.
    Am J Surg Pathol; 2009 Jun 25; 33(6):914-24. PubMed ID: 19295407
    [Abstract] [Full Text] [Related]

  • 13. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
    Ullal A, Roberts M, Bulmer JN, Mathers ME, Wadehra V.
    Cytopathology; 2009 Dec 25; 20(6):359-66. PubMed ID: 18557985
    [Abstract] [Full Text] [Related]

  • 14. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. I. Adenocarcinoma in situ.
    Ayer B, Pacey F, Greenberg M, Bousfield L.
    Acta Cytol; 1987 Dec 25; 31(4):397-411. PubMed ID: 3604534
    [Abstract] [Full Text] [Related]

  • 15. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K, Misirlioğlu M, Firat P, Tuncer ZS, Tuncer S, Yildiz I, Ustaçelebi S.
    Mikrobiyol Bul; 2008 Apr 25; 42(2):273-82. PubMed ID: 18697425
    [Abstract] [Full Text] [Related]

  • 16. Early endocervical glandular neoplasia. II. Morphometric analysis of the cells.
    Clark AH, Betsill WL.
    Acta Cytol; 1986 Apr 25; 30(2):127-34. PubMed ID: 3457504
    [Abstract] [Full Text] [Related]

  • 17. The role of cytology in the diagnosis and follow-up of patients with cervical adenocarcinoma.
    Saigo PE, Wolinska WH, Kim WS, Hajdu SI.
    Acta Cytol; 1985 Apr 25; 29(5):785-94. PubMed ID: 3863425
    [Abstract] [Full Text] [Related]

  • 18. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions.
    Bousfield L, Pacey F, Young Q, Krumins I, Osborn R.
    Acta Cytol; 1980 Apr 25; 24(4):283-96. PubMed ID: 6932140
    [Abstract] [Full Text] [Related]

  • 19. [Primary microinvasive adenocarcinoma of the cervix. A clinical case].
    Martino A, Montanino Oliva M, Liguori S, Bonito M, D'Ermo G, Assogna M.
    Minerva Ginecol; 1997 Apr 25; 49(4):161-3. PubMed ID: 9206767
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T.
    Cancer; 2004 Apr 25; 102(2):100-8. PubMed ID: 15098254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.